CURRICULUM VITAE
Personal Information
Name Sung Shin (申聖)
Date of Birth 30 November 1977
Nationality Korean
Marital Status Married
Address (Office) Division Kidney and Pancreas Transplantation,
Department of Surgery, Asan Medical Center
388-1 Pungnap-2dong, Songpa-gu, Seoul 138-736, Korea
Telephone 082-02-3010-3964 (office)
Educational Background
February,1998 Finished premedical course, College of Medicine,
Korea University, Seoul, Korea
February,2002 Bachelor’s Degree, College of Medicine, Korea University, Seoul, Korea
February,2013 Master’s Degree, College of Medicine, Ulsan University, Seoul, Korea
February 2015 Doctor’s Degree, College of Medicine, Ulsan University, Seoul, Korea
Hospital Training
May, 2005 – February, 2006: Internship, Asan Medical Center, Seoul, Korea
March, 2006 – February, 2010: Residency in Surgery, Asan Medical Center, Seoul, Korea
March, 2010 – February, 2012: Clinical Fellowship in Vascular Surgery, Asan Medical Center, Seoul, Korea
March, 2012 – February, 2013: Assistant professor in Vascular Surgery, Asan Medical Center, Seoul, Korea
March, 2013 – February, 2017: Assistant professor in Surgery, Asan Medical Center, Seoul, Korea
March, 2017 – February, 2023: Associate professor in Surgery, Asan Medical Center, Seoul, Korea
March, 2023 – Current: Professor in Surgery, Asan Medical Center, Seoul, Korea
License and Certification
February,2002 Korean Medical License (No.77435)
February,2010 Korean Board of General Surgery (No.6505)
Awards
November, 2011 Young Investigator Award, 63th Annual Congress of the Korean Surgical Society
November, 2012 Best Abstract Award, 39th Annual Veith Symposium, International Society of Vascular Surgery
November, 2013 Best Abstract Award, 43th Annual Congress of the Korean Society for Transplantation
GCP certificatation
2011. 10. 21 GCP training for investigators
2012. 06. 16 ACREP summer workshop
2014. 07. 09 Basic GCP workshop
2016. 07. 24 Introduction to Clinical Research (KGCP)
2017. 08. 03 Basic GCP workshop
2018. 12. 07 Basic GCP workshop
Supervisory Activities
Graduate Students & Research Fellows
2018 Dr. I-Ji Jeong (MD) University of Ulsan College of Medicine
2019 Dr. Jee Yeon Kim (PhD) University of Ulsan College of Medicine
2019 Hey Rim Jung (MSc) University of Ulsan College of Medicine
2019 Dr. Hye Yeon Kim (MD) University of Ulsan College of Medicine
2021 Dr. Ye Eun Shim (MD) University of Ulsan College of Medicine
Research Funding
Fund from Ministry of Education
Transglutaminase type 2 as a biomarker to predict rejection or interstitial fibrosis and tubular atrophy of renal allograft (2014-2017)
Korean Society for Transplantation
Effects of tissue-resident natural killer cells on kidney allograft fibrosis
Fund from Ministry of Science & ICT
Development of diagnostic kit for urinary transglutaminase 2 as a biomarker for kidney allograft fibrosis (2016-2020)
Fund from National Research Foundation of Korea
An experimental study to evaluate the effect of exosomal miRNA on insulin resistance and to validate islet transplantation as type 2 diabetes treatment in a mouse model (2017-2020)
Asan Medical Center
The effect of natural killer cell on renal tubulointerstitial fibrosis in a mouse model (2014-2015)
Asan Medical Center
Experimental study to evaluate the effect of natural killer cells on rejection and/or chronic fibrosis of kidney allograft (2015-2016)
Asan Medical Center
In vivo and in vitro experimental studies to evaluate the effects of conventional or tissue-resident natural killer cells on renal allograft (2016)
Asan Medical Center
Experimental study to evaluate the effect of natural killer cells on rejection and/or chronic fibrosis of kidney allograft (2016-2017)
Asan Medical Center
An experimental study to evaluate the mechanism of insulin resistance of the type 2 diabetes using islet transplant mouse models (2014-2017)
Korean Organ Transplantation Registry (KOTRY)
Comparison of acute rejection and allograft survival in Korean kidney transplant recipients according to the dosage of anti-thymocyte globulin as an induction regimen: National cohort study (2021)
Fund from National Research Foundation of Korea
Development of urinary biomarkers for kidney allograft tubulointerstitial fibrosis (2021)
Korean Society for Transplantation
A rat model to identify tolerance induction in simultaneous heart-kidney transplantation compared to heart transplantation alone (2021)
Asan Medical Center
To discover a new therapeutic target for antibody-mediated rejection which is one of main causes of long-term graft failure after kidney transplantation (2021-2023)
Asan Medical Center
Single-cell RNA-sequencing for verifying a mechanism of antibody-mediated rejection after kidney transplantation (2021)
Intellectual Properties and Patents
1. 특허번호: 10-2039815
특허명: 신장이식 후 이식 장기의 염증 진단 또는 예측용 바이오마커
출원국가: 대한민국
출원일: 2018.02.06 (10-2018-0014699)
등록일: 2019.10.28
2. 특허번호: 10-2039816
특허명: 신장이식 후 이식 장기의 섬유증 진단 또는 예측용 바이오마커
출원국가: 대한민국
출원일: 2018.02.06 (10-2018-0014700)
등록일: 2019.10.28
3. 특허번호: 10-2019-0074073
특허명: 신장이식 후 항체 매개성 거부반응의 진단 또는 예측을 위한 소변 엑소좀 바이오마커
출원국가: 대한민국
출원일: 2020.06.22
등록일: 2021.11.16
4. 특허번호: 10-2019-0074074
특허명: 신장이식 후 T세포 매개성 거부반응의 진단 또는 예측을 위한 소변 엑소좀 바이오마커
출원국가: 대한민국
출원일: 2019.06.21
등록일: 2022.01.07
5. 특허번호: 10-2019-0074075
특허명: 신장이식 후 BK 바이러스 신병증의 진단 또는 예후 예측을 위한 소변 엑소좀 바이오마커
출원국가: 대한민국
출원일: 2019.06.21
등록일: 2022.01.03
6. 특허번호: 10-2020-0108171
특허명: 신장이식 후 항체 매개성 거부반응의 진단을 위한 소변 엑소좀 유래 miRNA 유전자 바이오마커 및 이의 용도
출원국가: 대한민국
출원일: 2020.08.26
등록일: 2023.02.27
7. 특허번호: 10-2019-0104724
특허명: 신장이식 후 T 세포 매개성 거부반응의 진단을 위한 소변 엑소좀 유래 miRNA 유전자 바이오마커 및 이의 용도
출원국가: 대한민국
출원일: 2019.08.26
등록일: 2023.02.27
8. 특허번호: 10-2019-0104725
특허명: BK 바이러스 신병증의 진단을 위한 소변 엑소좀 유래 miRNA 유전자 바이오마커 및 이의 용도
출원국가: 대한민국
출원일: 2019.08.26
9. 특허번호: 10-2020-0052363
특허명: 신장이식 후 항체매개성 거부반응 진단 및 예후 예측을 위한 NK 세포 수용체 및 이의 용도
출원국가: 대한민국
출원일: 2020.04.29
Featured Lectures & Presentation
Minnesota University Symposium 2017 (Minnesota, USA)
Biomarker candidate discovery for kidney transplantation prognosis monitoring via urinary exosome proteome analysis (July, 2017)
The 14th Spring Symposium of the Korean Society for Transplantation (Gyeongju, Korea)
Tips for management of grant and outcomes for transplantation research (March, 2018)
BST (Basic Science for Transplantation) 2018 (Rotherdam, Netherland)
Biomarker candidate discovery for kidney transplantation prognosis monitoring via urinary exosome proteome analysis (October, 2018)
ATW (Asian Transplant Week) 2018 (Busan, Korea)
The Effect of Tissue-Resident NK cells on Renal Fibrosis in Kidney Transplantation Patients (November, 2018)
Technical pitfalls in pancreas transplantation (November, 2018)
The 14th Asan Medical Center Surgery Symposium [30 Years Memory of AMC Surgery] (Seoul, Korea)
Precision medicine in transplantation (June, 2019)
ATW (Asian Transplant Week) 2019 (Gyeongju, Korea)
Metabolic improvement after pancreas transplantation (October, 2019)
The 16th Spring Symposium of the Korean Society for Transplantation (Korea) (Virtual symposium)
Indications and optimal dose of ATG and basiliximab (July, 2020)
ATW (Asian Transplant Week) 2020 (Seoul, Korea) (Virtual symposium)
Induction and maintenance immunosuppression for pancreas transplantation (December, 2020)
Precision medicine in kidney transplantation (December, 2020)
The 11th Asan Medical Center Robotic Surgery Symposium (Virtual symposium)
Robot-assisted kidney transplantation: Experiences at Asan Medical Center (February, 2021)
The Spring Symposium of the Korean Biochip Society 2021 (Hongcheon, Korea)
Liquid biopsy for precision medicine in transplantation (June, 2021)
EMKT (Expert Meeting in Kidney Transplantation) 2021 (Seoul, Korea)
Early failure of expanded criteria kidney donor (June, 2021)
2021 SANOFI Kidney Transplant FORUM (Seoul, Korea)
Current Use of Anti-Thymocyte Globulin as Induction Regimen in Living Donor. Kidney Transplantation (September, 2021)
2021 ASTELLAS SYMPOSIUM (Webinar)
Robot-assisted kidney transplantation: Golden age of a smart transplant surgeon (November, 2021)
Surgical Grand Round, Asan Medical Center (Webinar)
Robot-assisted kidney transplantation (April, 2022)
2022 EMKT ASTELLAS SYMPOSIUM (Seoul, Korea)
Robot-assisted kidney transplantation in immunological high-risk patients (July, 2022)
2022 CMC Transplant Symposium (Seoul, Korea)
Robot-assisted kidney transplantation in immunological high-risk patients (September, 2022)
2022 Severance Hospital kidney transplant 5000 cases symposium (Seoul, Korea)
Robotic Kidney Transplantation: Transplant Outcomes (September, 2022)
2022 Korea University Transplant Symposium (Seoul, Korea)
Robotic Kidney Transplantation: Golden age of a smart transplant surgeon (September, 2022)
2022 WCES (Busan, Korea)
Robot-assisted kidney transplantation in immunological high-risk patients (October, 2022)
2022 KSEV (Jeju, Korea)
Clinical application of extracellular vesicle biomarkers in transplantation (November, 2022)
2022 Bundang Seoul National University Hospital SGR (Bundang, Korea)
Robot-assisted kidney transplantation: Golden age of a smart transplant surgeon (November, 2022)
ATW (Asian Transplant Week) 2020 (Seoul, Korea)
Do we need Certican to improve long-term graft and patient outcomes in Kidney transplantation? (November, 2022)
2023 Hanyang University Robotic Surgery Symposium (Seoul, Korea)
Robotic Kidney Transplantation: Golden age of a smart transplant surgeon (January, 2023)
2023 Asan Medical Center SGR (Seoul, Korea)
EXOSOMES: Real ANT-MAN in Transplantation (May, 2023)
2023 Congress of Asian Society of Transplantation (CAST) 2023 (Hong Kong)
Robotic Kidney Transplantation (August, 2023)
Professional Activities
March, 2016 – Current: Member of Kidney Committee in Korean Organ Transplantation Registry (KOTRY)
March, 2017 – Current: Member of Educational Committee in the Korean Society for Transplantation
March, 2017 – Current: Assistant Dean of University of Ulsan College of Medicine, Seoul, Korea
March, 2019 – Current: Member of Research Committee in the Korean Society for Transplantation
March, 2022 – Current: Member of International Collaboration Committee in the Korean Society for Transplantation
March, 2022 – Current: Member of Kidney and Pancreas Advisory Group in the National Institute of Organ, Tissue and Blood Management
Scientific Publications (Journal)
1. Kim JT, Kwon TW, Cho Y, Shin S, Lee S, Moon D : Multidisciplinary treatment and long-term outcomes in six patients with leiomyosarcoma of the inferior vena cava. J Korean Surg Soc. 2012 Feb; 82(2):101-9. doi: 10.4174 /jkss . 2012.82.2.101. Epub 2012 Jan 27. Pub Med PMID: 22347712; 2.
2. Oh S, Cho YP, Kim JH, Shin S, Kwon TW, Ko GY
Symptomatic spontaneous celiac artery dissection treated by conservative management: serial imaging findings. Abdom Imaging. 2011 Feb;36(1):79-82.
doi: 10.1007/s00261-010-9657-x. PubMed PMID
3. Shin S, Kwon TW, Cho YP, Shin JH, Yi A, Kim H, Kim GE
Preoperative magnetic resonance angiography as a predictive test for cerebral ischemia During carotid endarterectomy World J Surg. 2013 Mar;37(3):663-70
4. Shin S, Cho YP, Jun H, Park H, Hong HN, Kwon TW
Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix Journal of Vascular Surgery. 2013May;57(5):1362-70
5. Shin S, Han Y, Park H, Chung YS, Ahn H, Kim CS, Cho YP, Kwon TW
Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma Journa of Vascular Surgery. 2013 Oct;58(4): 1021-7
6. Shin S, Kwon TW, Cho YP, Lee JY, Park H, Han Y
Preoperative cardiac evaluation by dipyridamole thallium-201 myocardial perfusion scan provides no benefit in patients with abdominal aortic aneurysm. World Journal of Surgery. 2013 Dec;37(12):2965-71
7. Shin S, Han DJ, Kim YH, Han S, Choi BH, Jung JH, Cho HK
Long-term Effects of Delayed Graft Function on Pancreas Graft Survival After Pancreas Transplantation. Transplantation. 2014 Dec 27;98(12):1316-22.
8. Shin S, Kim YH, Choi BH, Choi JY, Jung JH, Cho HK, Han DJ.
Long-term impact of human leukocyte antigen mismatches combined with expanded criteria donor on allograft outcomes in deceased donor kidney transplantation Clin Transplant. 2015 Jan;29(1):44-51
9. Kim SH, Lee SO, Park IA, Kim SM, Park SJ, Yun SC, J ung JH, Shin S, KimYH, ChoiSH, Kim YS, Woo JH, Park SK, Park JS, Han DJ. : Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ-releasing assay: an exploratory randomized controlled trial.J Antimicrob Chemother. 2015 May;70(5):1567-72.
10. Jun H, Han Y, Park H, Shin S, Cho YP, Kwon TW : Clinical outcomes
related to the level of clamping in inferior vena cava surgery.
World J Surg.2015 May;39(5):1294-300
11. Shin S, Kim YH, Cho YM, Park YS, Choi BH, Choi JY, Han DJ : Interpreting CD56+ and CD163+ infiltrates in early versus late renal transplant biopsies American Journal of Nephrology. 2015 Jun 18;41(4-5):362-369.
12. Kim SH, Lee HJ, Kim SM, Jung JH, Shin S, Kim YH, Sung H, Lee SO, Choi SH, Kim YS, Woo JH, Han DJ : Diagnostic Usefulness of Cytomegalovirus (CMV)-Specific T Cell Immunity in Predicting CMV Infection after KidneyTransplantation: A Pilot Proof-of-Concept Study. Infect Chemother. 2015 Jun;47(2):105-10.
13. Choi BM, Park SK, Shin S, Cho YP, Kwon TW, Choi YJ, Lee EK, Noh GJ. Neurologic Derangement and Regional Cerebral Oxygen Desaturation Associated With Patency of the Circle of Willis During Carotid Endarterectomy. J Cardiothorac Vasc Anesth. 2015 Oct;29(5):1200-5. doi: 10.1053/j.jvca .2015.05.059. Epub 2015 May 8.
14. Kwon YJ, Kwon TW, Um EH, Shin S, Cho YP, Kim JM, Lee SH, Hwang SJ. Anatomical Popliteal Artery Entrapment Syndrome Caused by an Aberrant Plantaris Muscle. Vasc Specialist Int. 2015 Sep;31(3):95-101. doi: 10.5758/vsi. 2015.31.3.95. Epub 2015 Sep 30.
15. Park H, Kwon TW, Kwon SU, Kang DW, Kim JS, Chung YS, Shin S, Han Y, Cho YP : A Retrospective 10-Year, Single-Institution Study of Carotid Endarterectomy with a Focus on Elderly Patients. J Clin Neurol. 2016 Jan;12(1):49-56. doi: 10.3988/jcn .2016.12.1.49.
16. Kim T, Lee YM, Lee SO, Choi SH, Kim YS, Woo JH, Sung H, Jung JH, Shin S, KimYH, Kang YA, Lee YS, Lee JH, Lee JH, Lee KH, Park SK, Han DJ, Kim SH. : Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy. Korean J Intern Med. 2016 Sep;31(5):961-70. doi: 10.3904/kjim. 2015.079. Epub 2016 Apr 8.
17. Han K, Ko HK, Tsauo J, Shim DJ, Kim Y, Ko GY, Han DJ, Shin S, KimYH. Endovascular Management for the Treatment of Pancreas Transplant Venous Thrombosis: A Single-Center Experience. J Vasc Interv Radiol. 2016 Jun;27 (6):882-8. doi: 10.1016/j.jvir. 2016.02.022 Epub 2016 Apr 20.
18. Kwon H, Kim YH, Choi JY, Sung S, Jung JH, Park SK, Han DJ : Analysis of 4000 kidney transplantations in a single center : Across immunological barriers. Medicine (Baltimore). 2016 Aug;95(32):e4249.
19. Shin S, Kim YH, Kim SH, Lee SO, Kwon HW, Choi JY, Han DJ. Incidence and differential characteristics of culture-negative fever following pancreas transplantation with anti-thymocyte globulin induction. Transpl Infect Dis. 2016 Oct;18(5):681-689
20. Choi JY, Jung JH, Shin S, Kim YH, Han DJ: Living donor renal transplantationin patients with antiphospholipid syndrome : A case report. Medicine (Baltimore). 2016 Nov;95(46):e5419.
21. Go H, Shin S, Kim YH, Han DJ, Cho YM. : Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering In the diagnosis of chronic active/acute antibody-mediated rejection. Transpl Int. 2017 Apr ;30(4):398-409. doi: 10.1111/tri.12921. Epub 2017 Mar 5.
22. Shin S, Kim YH, Jung CH , Choi JY, Kwon HW, Jung JH, Han DJ : Long-term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients. Transplantation. 2017 Jun;101(6):1254-1260
23. Choi JY, Jung JH, Shin S, Kim YH, Han DJ. Association between the pancreas transplantation and survival of patients with diabetes: A single center experience. PLoS One. 2017 Nov 2;12(11):e0186827
24. Kwon JS, Kim T, Kim SM, Sung H, Shin S, Kim YH, Shin EC, Kim SH, Han DJ. Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients. Immune Netw. 2017 Oct;17(5):317-325
25. Kim SH, Lee HS, Lee HJ, Kim SM, Shin S, Park SH, Kim KJ, Kim YH, Sung H, Lee SO, Choi SH, Yang SK, Kim YS, Woo JH, Han DJ. Clinical applications of interferon-γ releasing assays for cytomegalovirus to differentiate cytomegalovirus disease from bystander activation: a pilot proof-of-concept study. Korean J Intern Med. 2017 Sep;32(5):900-909
26. Kim YJ, Shin S, Han DJ, Kim YH, Lee JY, Yoon YH, Kim JG Long-term Effects of Pancreas Transplantation on Diabetic Retinopathy and Incidence and Predictive Risk Factors for Early Worsening. Transplantation. 2018 Jan;102(1):e30-e38
27. Shin S, Jung CH, Choi JY, Kwon HW, Jung JH, Kim YH, Han DJ. Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function. PLoS One. 2018 Jan 29;13(1):e0191421
28. Choi JY, Jung JH, Kwon HW, Shin S, Kim YH, Han DJ. Does Enteric Conversion Affect Graft Survival After Pancreas Transplantation with Bladder Drainage? Ann Transplant. 2018 Feb 2;23:89-97
29. Jeon JW, Kim SM, Cho H, Baek CH, Kim H, Shin S, Kim YH, Han DJ, Kim SB. Presence of hepatitis B surface antibody in addition to hepatitis B core antibody confers protection against hepatitis B virus infection in hepatitis B surface antigen-negative patients undergoing kidney transplantation. Transplantation. 2018 Oct;102(10):1717-1723.
30. Kwon H, Kim YH, Choi JY, Shin S, Jung JH, Park SK, Han DJ. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches. Clin Transplant. 2018 Jun;32(6):e13266
31. Kim T, Lee HJ, Kim SM, Jung JH, Shin S, Kim YH, Sung H, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH, Han DJ. Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant. Korean J Intern Med. 2018 Jun 7.
32. Wee YM, Lee HW, Choi MY, Jung HR, Choi JY, Kwon HW, Jung JH, Kim YH, Han DJ, Shin S. A composite of urinary biomarkers for differentiating between tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy in kidney allografts. Ann Hepatobiliary Pancreat Surg. 2018 Nov;22(4):310-320.
33. Lee M, Mok J, Kim DK, Shim TS, Koh WJ, Jeon D, Lee T, Lee SH, Kim JS, Park JS, Lee JY, Kim SY, Lee JH, Jo KW, Jhun BW, Kang YA, Ahn JH, Kim CK, Shin S, Song T, Shin SJ, Kim YR, Ahn H, Hahn S, Won HJ, Jang JY, Cho SN, Yim JJ. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial. Trials. 2019 Jan 16;20(1):57.
34. Kim HY, Choi JY, Kwon HW, Jung JH, Han M, Park SK, Kim SB, Lee SK, Kim YH, Han DJ, Shin S. Comparison of Clinical Outcomes Between Preemptive Transplant and Transplant After a Short Period of Dialysis in Living-Donor Kidney Transplantation: A Propensity-Score-Based Analysis. Ann Transplant. 2019 Feb 11;24:75-83.
35. Choi MY, Wee YM, Kim YH, Shin S, Yoo SE, Han DJ. Novel colchicine derivatives enhance graft survival after transplantation via suppression of T-cell differentiation and activity. J Cell Biochem. 2019 Aug;120(8):12436-12449.
36. Kwon H, Kim YH, Kim JY, Choi JY, Shin S, Jung JH, Park SK, Han DJ. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection. Clin Transplant. 2019 May;33(5):e13533.
37. Kim JY, Wee YM, Choi MY, Jung HR, Choi JY, Kwon HW, Jung JH, Cho YM, Go H, Han M, Kim YH, Han DJ, Shin S. Urinary transglutaminase 2 as a potent biomarker to predict interstitial fibrosis and tubular atrophy of kidney allograft during early posttransplant period in deceased donor kidney transplantation. Ann Surg Treat Res. 2019 Jul;97(1):27-35.
38. Wee YM, Go H, Choi MY, Jung HR, Cho YM, Kim YH, Han DJ, Shin S. Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy. BMB Rep. 2019 Sep;52(9):554-559
39. Kim JY, Jung SC, Ko Y, Kim DH, Choi JY, Kwon H, Jung JH, Kim YH, Han DJ, Shin S. Intracranial aneurysms in patients receiving kidney transplantation for autosomal dominant polycystic kidney disease. Acta Neurochir (Wien). 2019 Sep 9. doi: 10.1007/s00701-019-04060-7.
40. Hey Rim Jung, Mi Joung Kim,Yu-Mee Wee, Jee Yeon Kim, Monica Young Choi, Ji Yoon Choi, Hyunwook Kwon, Joo Hee Jung ,Yong Mee Cho , Heounjeong Go,
Sang-Yeob Kim,Yeon-Mi Ryu,Yun Jae Kim,Young Hoon Kim, Duck Jong Han & Sung Shin
CD56+CD57+ infiltrates as the most predominant subset of intragraft natural killer cells in renal transplant biopsies with antibody-mediated rejection.
Sci Rep2019 Nov 12;9(1):16606
41. Jee Yeon Kim, Dong Hyun Kim, Ye-Jee Kim, Ji Yoon Choi, Hyunwook Kwon, Youngmin Ko, Joo Hee Jung, Chung Hee Baek, Hyosang Kim, Su-Kil Park, Soon Bae Kim, Sang Koo Lee, Yura Lee, Young Hoon Kim, Duck Jong Han, Sung Shin
Long-Term Outcome of Live Kidney Donation in South Korea. Ann Transplant 2020;25:e923065 :: DOI: 10.12659/AOT.923065
42. Jee Yeon Kim, Mun Chae Choi, Dong Hyun Kim, Youngmin Ko, Seong Jun Lim, Joo Hee Jung, Hyunwook Kwon, Young Hoon Kim, Sung Shin, Duck Jong Han. Outcomes of Living-Donor Kidney Transplantation in Female Recipients with Possible Pregnancy-Related Pre-Sensitization According to Donor Relationship. Ann Transplant 2020 Nov 6;25:e925229.
43. Shim YE, Shin S, Ko Y, Kim DH, Lim SJ, Jung JH, Kwon H, Kim YH, Kim SH, Lee SO, Han DJ. Serum procalcitonin as a biomarker for differentiating between infectious and non-infectious fever after pancreas transplantation. Clin Transplant. 2021 Apr;35(4):e14224.
44. Choi MY, Lim SJ, Kim MJ, Wee YM, Kwon H, Jung CH, Kim YH, Han DJ, Shin S. Islet isograft transplantation improves insulin sensitivity in a murine model of type 2 diabetes. Endocrine. 2021 Jun;72(3):660-671.
45. Ko Y, Shin S, Mun S, Kim DH, Lim SJ, Jung CH, Kwon H, Jung JH, Kim YH, Han DJ. Lack of Improvement in Insulin Sensitivity After Pancreas Transplantation in Recipients With a High Level of Calcineurin Inhibitors. Pancreas. 2021 Apr 1;50(4):587-594.
46. Lim SJ, Ko Y, Kim DH, Jung JH, Kwon H, Kim YH, Shin S. Robot-assisted Kidney Transplantation. J Vis Exp. 2021 Jul 19;(173).
47. Kwon H, Kim YH, Ko Y, Lim SJ, Jung JH, Baek CH, Kim H, Park SK, Shin S, Cho YP. Pure T-cell mediated rejection following kidney transplant according to response to treatment. PLoS One. 2021 Sep 3;16(9):e0256898.
48. Jang HW, Jung CH, Ko Y, Lim SJ, Kwon HE, Jung JH, Kwon H, Kim YH, Shin S. Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve β cell function. Ann Surg Treat Res. 2021 Sep;101(3):187-196.
49. Jang HW, Bae S, Ko Y, Lim SJ, Kwon HE, Jung JH, Cho HY, Go H, Kwon H, Kim YH, Kim SH, Shin S. Acute T cell-mediated rejection after administration of the BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient: a case report. Korean J Transplant. 2021 Dec 31;35(4):253-256.
50. Hong JJ, Hwang S, Moon DB, Kim YH, Shin S, Kim IO, Lee SR, Lee AY, Woo J. An analysis of the number of liver and kidney transplantations during COVID-19 pandemic in Korea. Korean J Transplant. 2021 Dec 31;35(4):247-252.
51. Kim MJ, Lim SJ, Ko Y, Kwon HE, Jung JH, Kwon H, Go H, Park Y, Kim TK, Jung M, Pack CG, Kim YH, Kim K, Shin S. Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Antibody-Mediated Rejection after Kidney Transplantation. Biomedicines. 2022 Sep 21;10(10):2346.
52. Yang EH, Shin S, Kim YH, Jeong IG, Hong B, Baek CH, Kim H, Kim SB. No difference in follow-up estimated glomerular filtration rate between hypertensive and matched nonhypertensive kidney donors. Nefrologia (Engl Ed). 2022 Dec 6:S2013-2514(22)00148-1.
53. Kim JM, Ko Y, Choi M, Kwon HE, Lee JJ, Jung JH, Kwon H, Kim YH, Shin S. Comparison of long-term outcomes in simultaneous pancreas-kidney transplant versus simultaneous deceased donor pancreas and living donor kidney transplant. Sci Rep. 2023 Jan 2;13(1):49.
54. A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients. PLoS One. 2023 Mar 1;18(3):e0280924.
Scientific Publications (Textbook)
1. 신성. 외과수술아틀라스 (Atlas of Surgical Procedures) Second Edition, 군자출판사, Section 7 이식 (췌장 구득, 신장 구득), 800-808, 2020.11.05.